Raymond James raised the firm’s price target on Boston Scientific (BSX) to $119 from $101 and keeps a Strong Buy rating on the shares. Boston Scientific is still one of the most dynamic companies in ...
Raymond James Financial reported a 19.5% rise in first-quarter profit on Wednesday, bolstered by strong performance in its capital markets and wealth management businesses.
Raymond James Financial (RJF) reported impressive financial results for Q1 FY2025, exceeding analysts' expectations with an earnings per share (EPS) of $2.93, compared to the forecasted $2.62. The ...